Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Chronic Hepatitis B · Recurrent Genital Herpes Simplex Type 2 · ASMB

ASSEMBLY BIOSCIENCES

ASSEMBLY BIOSCIENCES, INC.

ASSEMBLY BIOSCIENCES patent portfolio — 14 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
2 Tower Pl, 7th Floor, South San Francisco, California 94080, US HQ
2014 Founded
99 Employees
Public company Type
ASMB · NYSE Ticker
Company details
Status
Public
HQ
2 Tower Pl, 7th Floor, South San Francisco, California 94080, US
Founded
2014
Employees
99
Programs
15
Drugs
10
Patents
14
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

ASSEMBLY BIOSCIENCES patents

14 pharmaceutical patents indexed for ASSEMBLY BIOSCIENCES. 0 expire within 24 months.

ASSEMBLY BIOSCIENCES has 14 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

14 patents

Patent portfolio

  1. US 12030869

    5-membered heteroaryl carboxamide compounds for treatment of HBV

    Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11814376

    Hepatitis b core protein modulators

    Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11560370

    5-membered heteroaryl carboxamide compounds for treatment of HBV

    Expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11331365

    Multispecific protein drug and library thereof, preparing method therefor and application thereof

    Expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11078170

    Cyclic sulfamide compounds and methods of using same

    Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11040965

    Process for making Hepatitis B core protein modulators

    Expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10987360

    Hepatitis B core protein modulators

    Expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10968211

    Hepatitis B core protein modulators

    Expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10947224

    Hepatitis B core protein allosteric modulators

    Expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10766890

    Hepatitis B core protein modulators

    Expires Mon Sep 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10392379

    Hepatitis B core protein modulators

    Expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10377748

    Hepatitis B core protein modulators

    Expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10273228

    Hepatitis B viral assembly effectors

    Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10183936

    Hepatitis B core protein allosteric modulators

    Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does ASSEMBLY BIOSCIENCES have?

14 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do ASSEMBLY BIOSCIENCES patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.